Phase I/II clinical trial on autologous cancer-testis antigen targeted dendritic cell immunotherapy (TriMixDC) for patients with inoperable pretreated colorectal cancer Ghent University
2012-206: Phase I/II clinical trial on autologus cancer-testis antigen targeted dendritic cell immunotherapy (TriMixDC) for patients with inoperable pretreated colorectal cancer
Stichting tegen Kanker
2012-206